Home

Ekso Bionics Holdings, Inc. - Common Stock (EKSO)

0.4189
+0.0089 (2.17%)
NASDAQ · Last Trade: Apr 3rd, 12:50 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Competitors to Ekso Bionics Holdings, Inc. - Common Stock (EKSO)

Cyberdyne, Inc.

Cyberdyne is recognized for its HAL (Hybrid Assistive Limb) exoskeletons, which are used in both medical rehabilitation and industrial applications. Their unique approach to integrating robotics with human movement gives them a competitive advantage, as their technology is designed to enhance user capabilities while reducing fatigue. Cyberdyne's strong presence in the Japanese market and partnerships with health care institutions provide them with a strategic edge that can lead to wider adoption compared to Ekso.

Human Talents

Human Talents is a startup specializing in neuro-rehabilitation robotics, targeting individuals with movement disorders. While they are newer and smaller than Ekso Bionics, their innovative approach and integration of AI technologies for personalized rehabilitation could disrupt the market. Human Talents leverages emerging trends in machine learning and patient-specific data to offer tailored solutions, which may appeal to a niche audience, but they currently lack the robust endorsement and market presence seen in larger players.

MediTouch, Inc.

MediTouch develops wearable motion capture devices and rehabilitation technologies that complement existing physical therapies. They compete with Ekso Bionics by offering digital health solutions that enhance patient experience and tracking capabilities during rehabilitation. While they focus more on the software and rehabilitation aspect without the hardware exoskeletons, their synergy with physiotherapy practices and growing adoption of digital health trends positions them as a supportive competitor rather than a direct rival to Ekso's hardware-focused approach.

Parker Hannifin Corporation PH -9.67%

Parker Hannifin has entered the bionics space by leveraging their expertise in motion and control technologies to develop advanced robotics and exoskeletons. They compete with Ekso Bionics primarily through their extensive industrial background and advanced engineering capabilities, allowing them to create customized solutions for workforce applications. While Parker's focus may be more on industrial applications and less on medical rehabilitation, their strong reputation in manufacturing gives them a competitive edge in market trust and resource availability.

ReWalk Robotics Ltd.

ReWalk Robotics focuses on developing exoskeletons for individuals with spinal cord injuries. They compete with Ekso Bionics by offering a similar product range aimed at enhancing mobility and rehabilitation for patients. ReWalk's equipment is clinically validated and has received medical device approval in several countries, providing a strong advantage in terms of regulatory compliance and market trust. This positions ReWalk favorably in the rehabilitation sector, potentially making them a leader in clinical settings.